News

FDA Approves Liquidia Corporation (LQDA)’s YUTREPIA Amid Patent Dispute
Liquidia Corporation (NASDAQ:LQDA) announced today that the U.S. Food and Drug Administration (FDA) has approved YUTREPIA ...